Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Dexcom Inc. (DXCM:NASDAQ), powered by AI.
Dexcom Inc. is currently trading at $75.37. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Dexcom Inc. on Alpha Lenz.
Dexcom Inc.'s P/E ratio is 35.2.
“Dexcom Inc. trades at a P/E of 35.2 (premium valuation) with strong ROE of 34.5%. 3Y revenue CAGR of 17.0% highlights clear growth momentum.”
Ask for details →Dexcom Inc. is a prominent player in the medical technology sector, specializing in continuous glucose monitoring (CGM) systems for diabetes management. The company's primary function is to develop and distribute innovative CGM devices that provide real-time glucose readings, allowing individuals with diabetes to make informed decisions about their health. Dexcom’s products play a critical role in healthcare by offering an alternative to traditional fingerstick testing, thus improving quality of life for many users. The company impacts several sectors, most notably within healthcare and technology, by integrating advanced data analytics and wireless technology into its monitoring systems. This not only aids individuals in managing their glucose levels but also supports healthcare providers in delivering better patient care through data-driven insights. In the financial market, Dexcom Inc. is recognized for its contributions to the growing field of digital health solutions. The company has established itself as a leader in its niche, continuously pushing the boundaries of technology to offer more precise and user-friendly glucose monitoring options. Founded in 1999 and headquartered in San Diego, California, Dexcom remains at the forefront of diabetes management solutions.
“Dexcom Inc. trades at a P/E of 35.2 (premium valuation) with strong ROE of 34.5%. 3Y revenue CAGR of 17.0% highlights clear growth momentum.”
Ask for details →Dexcom Inc. (ticker: DXCM) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 10,200 employees. Market cap is $29.4B.
The current price is $75.37 with a P/E ratio of 35.17x and P/B of 10.71x.
ROE is 34.50% and operating margin is 19.56%. Annual revenue is $4.7B.